ASH2L and Huntington disease: Protein–protein interaction results uncovered that the interactions between KMT2D and WDR5, ASH2L and RBBP5 were markedly weaker after HD treatment, which was consistent with the results obtained from KMT2D LCD knockout cells (Fig. 6i).